Status and phase
Conditions
Treatments
About
The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
280 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Eve Taylor, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal